AVEO Pharmaceuticals, Inc.
AVEO
AVEO was delisted on the 19th of January, 2023.
61 hedge funds and large institutions have $42.3M invested in AVEO Pharmaceuticals, Inc. in 2014 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 12 increasing their positions, 26 reducing their positions, and 16 closing their positions.
3% more capital invested
Capital invested by funds: $41.2M → $42.3M (+$1.12M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
10% less funds holding
Funds holding: 68 → 61 (-7)
38% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 16
54% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 26
91% less call options, than puts
Call options by funds: $7K | Put options by funds: $81K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FRM
Fore Research & Management
New York
|
+$877K |
| 2 |
GCM
Gruss Capital Management
New York
|
+$694K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$301K |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$291K |
| 5 |
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Harrisburg,
Pennsylvania
|
+$192K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$1.67M |
| 2 |
State Street
Boston,
Massachusetts
|
-$950K |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
-$857K |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$704K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$455K |
AVEO Hedge Fund Activity: Q2 2014 in Review
61 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in AVEO Pharmaceuticals, Inc. (AVEO) for Q2 2014, worth a combined $42.3M — up 2.7% from $41.2M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of AVEO and 10 opened new positions — a net loss of 6 holders — while 26 trimmed existing stakes and 12 added.
The largest buyer was Fore Research & Management, opening a new position worth an estimated $877K. The largest seller was BlackRock Fund Advisors, cutting an estimated $1.67M.
- 61 institutional investors held AVEO Pharmaceuticals, Inc. (AVEO) as of Q2 2014, down from 68 in Q1 2014.
- Funds reported $42.3M of AVEO Pharmaceuticals, Inc. stock for Q2 2014, up 2.7% quarter-over-quarter.
- 10 funds opened new AVEO Pharmaceuticals, Inc. positions in Q2 2014 and 16 closed out, a net change of -6 holders.
- The largest AVEO Pharmaceuticals, Inc. buyer in Q2 2014 was Fore Research & Management, an estimated $877K added.
- The largest AVEO Pharmaceuticals, Inc. seller in Q2 2014 was BlackRock Fund Advisors, an estimated $1.67M sold.
Based on aggregated 13F filings for Q2 2014.